Section 3, National Institutes of Pharmaceutical Education and Research Act, 1998 – Definitions

3. Definitions

In this Act, unless the context otherwise requires,—

[(a) "appointed day", in relation to an Institute mentioned in column (3) of the Schedule, means the date of its establishment as mentioned against it in column (4) of that Schedule;]

(b)

"Board" means the Board of Governors of [an Institute] constituted under sub-section (3) of section 4;

(c)

"Chairperson" means the Chairperson of [an Institute ] nominated under clause (a) of sub-section (3) of section (4);

[(ca) "Council" means the Council established under sub-section (1) of section 30A; ]

(d)

"Dean" means the Dean of [an Institute ] appointed under section 17;

(e)

"Director" means the Director of [an Institute ] appointed under section 16;

(f)

"Fund" means the fund of [an Institute ] to be maintained under section 21;

(g)

"Institute" means any of the institutions mentioned in column (3) of the Schedule;

(ga)

"member" means a member of the Council nominated or elected under sub-section (2) of section 30A;

(gb)

"prescribed" means prescribed by rules made under this Act;

(gc)

"Schedule" means the Schedule to this Act;

(h)

"Senate" means the Senate of [an Institute ] referred to in section 13;

(i)

"Society" means the National Institute of Pharmaceutical Education and Research Society, Sector-67, S.A.S. Nagar (Mohali), District Ropar, Punjab registered under the Societies Registration Act, 1860 (21 of 1860);

(j)

"Statutes" and "Ordinances" mean the Statutes and the Ordinances of [an Institute ] made under this Act.

Amendment notes (4)

Subs w.e.f. 25-5-2022 . Subs. by Act 43 of 2021, s. 5, for clause (a) (w.e.f. 25-5-2022).
Subs w.e.f. 25-5-2022 . Subs. by s. 5, ibid., for "the Institute" (w.e.f. 25-5-2022).
Ins w.e.f. 25-5-2022 . Ins. by s. 5, ibid. (w.e.f. 25-5-2022).
Subs w.e.f. 25-5-2022 . Subs. by s. 5, ibid., for clause (g) (w.e.f. 25-5-2022)